<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Healthcare sector on FinanClub</title>
    <link>https://finan.club/tags/healthcare-sector/</link>
    <description>Recent content in Healthcare sector on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Aug 2023 07:20:47 +0000</lastBuildDate><atom:link href="https://finan.club/tags/healthcare-sector/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>CVS</title>
      <link>https://finan.club/us/cvs/</link>
      <pubDate>Sat, 12 Aug 2023 07:20:47 +0000</pubDate>
      
      <guid>https://finan.club/us/cvs/</guid>
      <description>score:39
Chances: Quality dividend stock with potential for growth when down. Positive earnings surprise and beats earnings expectations. Interest from insiders buying the stock. Diverse offerings catering to dividends or explosive growth. Strong performance in the reliable healthcare sector. Risks: Market volatility affecting stock performance.</description>
    </item>
    
    <item>
      <title>MRK</title>
      <link>https://finan.club/us/mrk/</link>
      <pubDate>Sat, 12 Aug 2023 06:56:32 +0000</pubDate>
      
      <guid>https://finan.club/us/mrk/</guid>
      <description>score:109
Chances: Stronger-than-expected second-quarter earnings indicate the company&amp;rsquo;s financial strength. Positive results from clinical trials and collaborations in the healthcare sector. Rise in revenue and better full-year sales forecast driven by strong Keytruda cancer-drug sales. Expansion of ongoing Phase 1 dose escalation trial for breast cancer vaccine in collaboration with Cleveland Clinic.</description>
    </item>
    
  </channel>
</rss>
